CRISPR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CRISPR 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. 

CEO
Samarth Kulkarni
CEOSamarth Kulkarni
Employees
Employees
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2013
Founded2013
Employees
Employees

CRSP Key Statistics

Market cap
5.00B
Market cap5.00B
Price-Earnings ratio
-8.35
Price-Earnings ratio-8.35
Dividend yield
Dividend yield
Average volume
1.91M
Average volume1.91M
High today
$56.90
High today$56.90
Low today
$51.15
Low today$51.15
Open price
$55.70
Open price$55.70
Volume
2.30M
Volume2.30M
52 Week high
$78.48
52 Week high$78.48
52 Week low
$39.59
52 Week low$39.59

Stock Snapshot

The current CRISPR(CRSP) stock price is $51.90, with a market capitalization of 5B. The stock trades at a price-to-earnings (P/E) ratio of -8.35.

On 2026-06-06, CRISPR(CRSP) stock moved within a range of $51.15 to $56.90. With shares now at $51.90, the stock is trading +1.5% above its intraday low and -8.8% below the session's peak.

Trading activity shows a volume of 2.3M, compared to an average daily volume of 1.91M.

The stock's 52-week range extends from a low of $39.59 to a high of $78.48.

The stock's 52-week range extends from a low of $39.59 to a high of $78.48.

CRSP News

Simply Wall St 1d
A Look At CRISPR Therapeutics Valuation After Casgevy Launch And Ongoing Gene Editing Pipeline Progress - simplywall.st

...

A Look At CRISPR Therapeutics Valuation After Casgevy Launch And Ongoing Gene Editing Pipeline Progress - simplywall.st
TipRanks 2d
Shareholders Approve New Incentive Plan and Governance Measures

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

58%

of 26 ratings
Buy
57.7%
Hold
42.3%
Sell
0%

People also own

Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.